Outcomes of MIST for BPH: A Single-Institution Prospective Study

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Benign Prostatic Hyperplasia
Interventions
PROCEDURE

Rezum

The Rezum device is inserted, a needle is deployed, and vapor is injected into the prostate for nine seconds. This vapor disperses between cells, then cools, releases heat, and gently disrupts the prostate's cells. Because of the initial swelling, a catheter is then inserted, which will remain for two to five days.

DEVICE

iTind

The iTind device is temporarily placed inside the prostatic urethra (the narrowed portion of the prostate), where it slowly expands and exerts gentle pressure at three precise points. The effect of the iTind is to widen the prostatic urethral opening through which urine can now flow more easily.

Trial Locations (1)

R3K 1M3

Men's Health Clinic, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER